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Abstract
The heterogeneous nature of today’s evolving health databases requires new techniques and
approaches to process these data and extract clinically useful information. This relevant
information obtained can be used to improve the response rate of cardiac resynchronization
therapy (CRT) in patients with heart failure. Hierarchical clustering (HC) which is an
unsupervised ML technique may uncover clusters within the bulk of data of patient population
which is useful for strategies towards precision and personalized medicine. This study aims to
investigate how HC can be used to automatically group a bulk of clinically acquired CRT data
into clusters and subgroups that could confer clinically relevant information. About 165 patient
data were used in the study and the analysis resulted in 4 different phenogroups with varying
response rates. Some features were statistically significant when compared within the subgroups.
Lastly, the study concludes that HC can be used to integrate and analyze different kinds of
clinical data to aid in the identification of HF patient subgroups that are likely to respond to
CRT.

viii

1. INTRODUCTION
Personalized medicine as a clinical model separates people into different groups. This
classification aids doctors and researchers to predict and tailor accurate, efficient and highly
effective treatments and prevention strategies to certain groups of patients with particular
ailment. As opposed to using generalized treatments for all groups of people with certain
diseases with little consideration to the differences in patients. Heart failure (HF) is a disease
known to have differing signs and symptoms in a variety of patient groups with some treatments
having little to no success. Cardiac resynchronization therapy (CRT) for HF patients is a therapy
where individualized treatments for every unique patient could help overcome the limitations of
traditional HF treatments.

1.1

Cardiac Resynchronization Therapy

CRT is a standard clinical treatment for a group of end-stage HF patients where a device sends
little electrical charges to both lower chambers of the heart to help them beat together in a
synchronized pattern which improves the heart’s ability to pump blood and oxygen to the body
[1]. The CRT procedure involves implanting a device the size of a pocket size watch just below
the collar done. CRT is considered for HF patients who have explored correcting their heart
condition through medication therapies without success. Although, CRT is suitable for HF
patients who have moderate to severe symptoms with irregular heartbeat. It is not suitable for
patients with diastolic heart failure, mild HF symptoms or patients whose left and right heart
chambers beat synchronously.
1.1.1.

Cardiac Resynchronization Therapy Devices

CRT devices help the heart beat more efficiently and help to monitor HF condition so that the
physician can provide the right treatment. A CRT device has two main components which are the
pulse generator and the thin insulated wires called leads which deliver a small amount of
electrical energy to the heart to help restore the normal timing of the heart. The two types of
CRT devices are the cardiac resynchronization therapy pacemaker (CRT-P) or biventricular
marker and the same device with a built-in implantable cardioverter defibrillator called cardiac
resynchronization therapy defibrillator (CRT-D) [1].
According to [2], CRT enhances outcome in patients with heart failure but also has substantial
nonresponse rates. Several studies have shown improved CRT response prediction that includes
varying criteria such as the Left Bundle Branch Block (LBBB), Left Ventricle (LV) activation
time, intrinsicoid deflection onset as well as the frequency content and area of the Q wave, R
wave and S wave (QRS). QRS shows the electrical impulse as it spreads through the ventricles
and indicates ventricular depolarization.
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Figure 1: An implanted CRT-P system [1]

Figure 2: An implanted CRT-D system [1]
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1.1.3

Cardiac Resynchronization Therapy Indications

The guidelines from the American Heart Association/American College of Cardiology
Foundation (AHA/ACCF) for the management of HF which was published in 2013 were
harmonized with the AHA/ACCF/Heart Rhythm Society (HRS) 2012 and referred to as the
updated ACC/AHA/HRS guidelines [3]. The criteria for CRT implantation are New York Heart
Association (NYHA) functional class II and III with sinus rhythm, Left ventricular Ejection
Fraction (LVEF) < 35%, QRS width > 150 ms or 120 to 150 ms with Ventricular Electrical
Dyssynchrony (ED) by LBBB. Although about 30% of patients do not respond to CRT due to
common variables such as low LVEF, sinus rhythm, LBBB pattern, QRS duration >150ms on
electrocardiogram (ECG) and the New York Heart Association (NYHA) class II, III, and
ambulatory IV symptoms. This study also includes not only the Electrical Dyssynchrony (ED)
data, which would be QRS enlargement (> 150 ms) and LBBB but also the presence of
Mechanical Desynchronization (MD).

1.2. Machine Learning
The current trend in data analysis is towards technical approaches such as Machine Learning
(ML) and even more powerful techniques like deep learning which uses neural networks to solve
complex problems. However, deep learning requires a large set of data and this volume of data is
often lacking in clinical medicine to aid better clinical predictions [4]. ML is a part of artificial
intelligence that gives computer systems the ability to learn automatically with little to no human
intervention and it adjusts its actions accordingly without being explicitly programmed. Machine
learning improves the analysis of large quantities of data and is being used in a variety of
applications like predictive analytics, email filtering and computer vision. Awan et al [5]
discussed the application of machine learning methods in diagnosis, classification, readmissions
and medication adherence in patients with heart failure. Also, ML techniques have been applied
to identify distinct phenogroups in HF patients with preserved ejection fraction (HFpEF) as well
as several diseases [6,7]. Thus, machine learning approaches may be used to improve CRT
response prediction in patients with heart failure.
Supervised ML is a kind of ML that learns from the analysis of a known training dataset and then
uses the learned labels to predict future events or analysis. While supervised ML provides targets
for any new input after sufficient training, it requires massive dataset to train on, interpretation of
result varies and it is susceptible to errors. In contrast, unsupervised ML requires no training or
labelling as it explores the unlabelled data and can draw inferences from datasets to describe
hidden structures [4]. Unsupervised ML groups or clusters patients together based on multiple
characteristics in the dataset, which could be clinical, demographic, or measured. The grouping
of similar patients together in varying groups or dimensions, then makes it possible to analyse
the similarities in the groups of patients and relate them to clinical outcomes or therapeutic
responses.
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1.2.1. Hierarchical Clustering
Hierarchical clustering (HC) works by grouping data objects into a tree of clusters and HC can
be further divided into agglomerative and divisive which simply refers to the hierarchical
decomposition being formed bottom-up or top-down respectively. HC technique is a good way to
reveal anatomical subgroups from clinical data as they do not need any prior information about
the population of study. Also, HC does not require conditioning of an expected number of
subgroups in contrast to K-means clustering that involves specifying a required number of
subgroups. Some studies have applied HC techniques to 3D patient shape data and the outcome
depends hugely on the clustering distance metrics and linkage option of choice [8].
Furthermore, HC results are graphically depicted in a tree-like structural diagram called a
dendrogram that shows how similar objects are grouped together, while dissimilar objects are
grouped on different branches of the tree. However, assessment of the similarity or dissimilarity
and clustering results of objects is dependent on the similarity or distance metric chosen where
low inter-object distance connotes high similarity. Also, the linkage function is another huge
determinant on how objects are linked together to form a subgroup. Choosing the appropriate
distance or linkage combination is necessary to achieve meaningful results.

1.3

Aim and Significance of Study

An area where clustering of patient groups could improve the selection of patients and accurately
predict their clinical outcome is in CRT for HF patients. This is due to the fact that despite clear
criteria for which patients should undergo CRT, a significant percentage of patients do not
respond to this treatment option [9]. This study hypothesized that new approaches based on
unsupervised ML techniques which incorporates demographic, clinical and Echocardiographic
(ECG) and SPECT MPI data including both electrical and mechanical dyssynchrony may be
used to better depict how ML can be utilized to phenogroup HF patients in correlation to their
characteristics and predict clinical response.
Supervised ML mainly trains a model on a labelled dataset where the input data is split into
training and test dataset and the algorithm learns to predict the output from the input data. Thus,
unsupervised ML is used for this study instead of supervised ML because our aim is to identify
hidden patterns or underlying grouping structure in our data in order to better predict HF patients'
subgroups that are likely to respond to CRT. We utilized data from ten centres in 8 countries
with NYHA functional class II, III and IV with sinus rhythm, LVEF < 35%, QRS width > 150
ms or 120 to 150 ms with Ventricular Electrical Dyssynchrony (ED) by Left Bundle Branch
Block (LBBB) to determine if HC as an unsupervised ML technique could help discover
unknown patterns in the data and to identify the patient subgroups that are more likely to respond
to CRT.

4

2. RELATED WORK
Several studies have tried to find parameters or factors that could significantly improve CRT
efficacy. The use of SPECT images to assess LV latest activation was shown in [10] to improve
the rate of placing LV on target and ultimately produced a positive improvement in CRT
response. Other studies have used machine learning approaches to predict mortality in patients
with coronary artery disease. Cikel et al [4] researched the use of ML to accurately phenogroup
selected CRT patients to determine trends that can result in improved CRT response. The study
used unsupervised learning methods to help in the identification of patients likely to respond to
the therapy by integrating clinical features with echocardiographic data on myocardial infarction
and left ventricular volume changes that were measured over an entire cardiac cycle.
The results from the study showed that full unsupervised ML techniques can provide a clinically
relevant classification of a heterogeneous group of HF patients which can aid the identification
of patient subgroups most likely to respond to particular therapies. However, the paper reiterated
that the feasibility of the proposed model for phenogrouping HF patients and in clinical decision
making should be assessed in a prospective controlled trial. Additionally, Matthew et al [9] also
used machine learning-based unsupervised clustering analysis to identify clinically distinct
phenotypic subgroups in a highly dimensional mixed-data group of individuals with heart failure
with preserved ejection fraction (HFpEF).This study was able to identify phenogroups of HFpEF
patients with distinct clinical characteristics and lasting outcomes.

3. METHODS
3.1

Study Design and Patient Population

The population used for this study has been previously used by a prospective, multicenter, nonrandomized trial: ‘Value of intraventricular synchronism assessment by gated-SPECT
myocardial perfusion imaging in the management of heart failure patients submitted to cardiac
resynchronization therapy’ (IAEA VISION-CRT) [11]. In brief, the VISION-CRT trial involves
subjects from ten centers in 8 countries (Brazil, Chile, Colombia, Cuba, India, Mexico, Pakistan,
and Spain). The main investigators of the respective countries recorded all the clinical, CRT and
follow-up information in individual forms for each patient. The data from the Myocardial
Perfusion Imaging by Gated Single Photon Emission Computed Tomography (gSPECT MPI)
were recorded too. The overall data was collected by the central management center in the IAEA
headquarters in Vienna. The subjects underwent a detailed clinical and gated SPECT MPI
evaluation before recruitment to the study and all patients provided written informed consent.
The criteria for patient inclusion were: symptomatic HF patients over 18 years old with NYHA
functional class II, III or ambulatory IV with HF for at least three months before enrollment; LV
ejection fraction ≤ 35% from ischemic or non-ischemic causes, measured according to the usual
5

procedure at the participating center for inclusion, although LVEFs used for analysis came from
nuclear core lab; sinus rhythm with LBBB configuration defined as a wide QRS duration ≥
120ms. The Exclusion criteria were: pregnancy or breast-feeding; arrhythmias that prevented the
gated acquisition; right bundle branch block; a major coexisting illness affecting survival less
than one year; acute coronary syndromes, coronary artery bypass grafting, or percutaneous
coronary intervention in the last 3 months before enrollment and within 6 months of CRT
implantation. The patients were classified as ‘responders’ to CRT if they had an increase of
LVEF > 5% or a decrease in End Systolic Volume (ESV) < -15% as measured by gated SPECT
MPI at follow up. Others were classified as non-responders.

3.2.

SPECT MPI evaluation

Gated SPECT scans were performed about 30 minutes after injection using 20-30mCi of 99mTcsestamibi or tetrofosmin of 740 to 1110 MBq. The images were acquired in gamma cameras
using 180° orbits with a complimentary 8 or 16 frames ECG-gating. The Ordered Subset
Expectation maximization (OSEM) method with three iterations and ten subsets and filtered by a
Butterworth filter to the power of 10 and a cut-off frequency of 0.3 cycles/mm were used to
reconstruct the images and this was done by Emory Reconstruction Toolbox (ERToolbox;
Atlanta, GA). The resulting reoriented short-axis images were sent to Emory Cardiac Toolbox
(ECTb4, Atlanta, GA) for automated accessing of LV function, including LVEF, left ventricular
end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV), LV shape,
including end-systolic eccentricity (ESE) and end-diastolic eccentricity (EDE), and LV
mechanical dyssynchrony and includes phase standard deviation (PSD) and phase bandwidth
(PBW) [11].

3.3.

Baseline Characteristics

The complete data of clinical assessment, baseline SPECT MPI, and clinical six-month followup data were obtained in only 177 patients out of the initial 199 patients that underwent CRT.
About 11 patients among the 177 patients died before follow-up and 1 patient had an extremely
low ESV which is an outlier caused by the low resolution of gated SPECT MPI when measuring
a small heart. This study finally utilized the data from 165 patients for its analysis. The
covariates consist of a range of domains including demographics, clinical variables, laboratory
data, SPECT MPI measurements and an electrocardiographic parameter. Overall, a total of 26
continuous and categorical variables were used in the clustering analysis.

3.4. Characterization of phenogroups
Agglomerative hierarchical clustering algorithm was used to group similar objects into clusters
such that each observation starts in its own cluster and pairs of clusters are merged as one moves
6

up the hierarchy. The hierarchical relationship between the different set of data is shown in a
tree-like diagram called a dendrogram. Furthermore, the distance between the data points on the
x-axis represents the dissimilarities between the points while the height of the blocks on y-axis
represents the distance between the clusters. Of the three most common linkage methods: single,
complete and average linkage methods, the complete linkage method was used to merge the
clusters in the dendrogram as it tends to find compact clusters of approximately equal diameters.
The complete linkage method also avoids the disadvantage of the alternate single linkage method
where clusters are forced together due to single objects being close to each other, even when
many of the objects in each cluster may be largely distinct to each other. The number of clusters
was chosen by drawing a horizontal line to the longest line that traverses the maximum distance
up and down without intersecting the merging points. This was done on our dendrogram at both
a distance 600 which gave 2 clusters and a distance of 400 which gave 4 clusters and the
respective numbers of clusters were analyzed separately. Having done the analysis, 4 clusters
were finally used for further analysis as it was more statistically significant.
After the clusters were grouped into four, the differences in demographics, clinical variables,
laboratory data, SPECT MPI measurements, and echocardiographic parameters were compared
between the phenogroups. Continuous variables were summarized in means and standard
deviations while categorical variables were summarized in numbers and percentages. The
differences between groups were tested using a one-way ANOVA for continuous variables and a
Chi-squared test for categorical variables. A p-value of <0.05 was considered statistically
significant. The resulting dendrogram was internally validated by shuffling the dataset and
reducing the number of rows and columns to create clusters and compare their differences in
terms of clinical characteristics and the response outcome. Clustering the phenogroup into 4
clusters was more statistically significant and the ML algorithm used for all the analysis in this
study was done in python version 3.

7

Figure 3: Code snippets of Hierarchical Clustering
Table 1. Baseline characteristics of the study patients by phenogroups
S/
N

FEATURES

OVERALL
AVERAGE
(meanSD)
(count(%))
N=165
(98R,67NR)
59%R

PHENOGROUP
ONE

PHENOGROUP
TWO

PHENOGROUP
THREE

PHENOGROUP
FOUR

n=42
n=81
(21R,21NR) (55R,26NR)
50%R
68%R

n=16
(10R,
6NR)
63%R

n=26
(12R,14NR)
46%R

GROUP
PVALUE

1

ACEI_or_ARB

136(82%)

29(69%)

72(89%)

14(88%)

21(81%)

0.049

2

Age

60±11

61±10

61±12

58±10

58±10

0.1

3

CAD

51(31%)

16(38%)

23(28%)

2(13%)

10(38%)

0.213

4

Concordance

40(25%)

12(29%)

16(20%)

6(38%)

6(23%)

0.412

5

DM

41(25%)

8(19%)

22(27%)

6(38%)

5(19%)

0.424

6

ECG_pre_QRSd

161±25

156±23

159±24

161±28

176.6±21

0.00092

7

Gender

M=31(74%
M=98(59%) )
F=67(41%) F=11(26%)

M=33(41%) M=13(81 M=21(81%
F=48(59%) %)
)
F=3(19%) F=5(19%)

0.0

8

HTN

97(59%)

29(69%)

40(49%)

11(69%)

0.116

9

LBBB

165(100%)

42(100%)

81(100%)

16(100%) 26(100%)

8

17(65%)

1.0

10

MI

35(21%)

11(26%)

12(15%)

11

NYHA

II=46(28%)
III=101
(61%)
IV=18
(11%)

II=12(29%) II=28(35%)
III=27(64%) III=47(58%)
IV=3(7%)
IV=6(7%)

II=3(19%) II=3(12%)
0.094
III=9(56% III=18(69%)
)
IV=5(19%)
IV=4(25%
)

12

Race
I = Africa
II = Asia
III = Caucasian
IV = Hispanic
V = Indian

I=17(10%)
II=6(4%)
III=23(14%)
IV=87(53%)
V=32(19%)

I=6(14%)
II=1(2%)
III=5(12%)
IV=24(57%)
V=6(14%)

I=4(5%)
II=3(4%)
III=14(17%)
IV=37(46%)
V=23(28%)

I=2(13%)
II=2(13%)
III=1(6%)
IV=8(50%
)
V=3(19%)

I=5(19%)
0.033
II=0(0%)
III=3(12%)
IV=18(69%)
V=0(0%)
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SPECT_pre_EDE

0.5±0.2

0.5±0.1

0.6±0.2

0.5±0.2

0.5±0.2

0.17

14

SPECT_pre_EDSI

0.8±0.1

0.8±0.1

0.8±0.1

0.9±0.1

0.9±0.1

0.13

15

SPECT_pre_EDV

257.6±105

277.8±38

176±44

476.3±55 347.1±30

<0.001

16

SPECT_pre_ESE

0.6±0.2

0.6±0.2

0.6±0.2

0.4±0.2

0.5±0.1

0.009

17

SPECT_pre_ESSI

0.8±0.1

0.8±0.1

0.8±0.1

0.9±0.1

0.9±0.1

0.004

18

SPECT_pre_ESV

192.7±96

209.2±28

117.4±37

396±62

275.2±27

<0.001

19

SPECT_pre_LVEF

27.7±10.3

24±7.0

34.1±9.5

17.1±5.1

20.6±6.0

0.003

20

SPECT_pre_PBW

152.4±73.8

191.7±66.3 106.5±49.7

239.9±47 178.2±64.9 0.24
.9

21

SPECT_pre_PSD

48.8±19.7

56.7±15.6

37.6±15.7

72.9±15.
2

55.8±17

0.09

22

Smoking

27(16%)

7(17%)

15(19%)

2(13%)

3(12%)

1.0

23

SPECT_pre_50scar

25±14.4

29.2±13.6

17.8±11.5

35.1±15

31±14.3

0.827

9

2(13%)

10(38%)

0.047

24

LVEF

25±6.0

24.5±4.4

27.2±5.6

20.4±5.4

22±6.7

25

Echo_pre_EDV

192±36.8

193.3±17

180.7±33

195.3±10 224.4±30

26

Echo_pre_ESV

149±37.9

155.3±21.6 132.3±30.8

0.005
0.0002

157±18.3 187.7±53.5 0.00006

4. RESULTS
Of the 165 patient data used in this unsupervised learning study, there was a 59% response rate
where 98 participants responded to CRT and 67 patients had no response. The race population
was 53% hispanics, 19% indians, 14% caucasian, 10% african and 4% asians. The baseline
characteristics of the study population are shown in Table 1. For all the patients, the age was 60
± 11 years, and 98 (59.4%) patients were male. Fifty-one (30.9%) patients had a previous history
of CAD while 97 (58.8%) had Hypertension (HTN). About 27(16%) are smokers while 41
(24.8%) had diabetes mellitus (DM). Although the study data has NYHA class II, III and IV,
NYHA class III was predominant in the data with a rate of 61%. Myocardial infarction was not
prevalent among the participants as it was present in only about 21%.
There were no statistically significant differences in age and the NYHA class distributions across
phenogroups. Participants in phenogroup 1 had the lowest mean of ECG_pre_QRSd and a high
number and rate of HTN as compared with the other groups. Phenogroup 2 had the highest
burden of DM and the most significant response rate in females. It is also the group with the
highest response rate and the least rate of hypertensive patients. While phenogroup 3 had the
least burden of CAD and MI and the highest rate of DM. Phenogroup 4 had the least responders
to CRT, the highest rate of NYHA class III patients, and the largest ECG_pre_QRSd mean as
compared with the other groups. While phenogroup 1 and 4 had the same intermediate rates of
both CAD at 38% and DM at 19%, phenogroup 1 and 3 had the same intermediate burden of
HTN at 69%.
Among SPECT MPI parameters, phenogroup 1 participants had an intermediate high mean
values for LVEF, SPECT_pre_LVEF, SPECT_pre_PSD and SPECT_pre_PBW as compared
with the other phenogroups.While phenogroup 2 had the least mean values for
SPECT_pre_EDV, SPECT_pre_ESV and SPECT_pre_50scar but has the highest mean and
standard deviation of SPECT_pre_LVEF when compared with the other groups. Phenogroup 3
had the highest means for SPECT_pre_PBW, SPECT_pre_PSD and SPECT_pre_50scar values.
The highest mean and standard deviation of SPECT_pre_ESV values are found in this group as
well. Finally, the highest mean and standard deviation of Echo_pre_ESV and Echo_pre_EDV
were in phenogroup 4.
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Figure 4: Hierarchical Clustering Dendrogram

Table 2: Dissimilarity between phenogroups
S/N

Phenogroup 1

Phenogroup 2

Phenogroup 3

Phenogroup 4

- Least mean of
ECG_pre_QRSd

- Highest responder group

- Has the highest
mean and a wider
range of
SPECT_pre_EDV
values

- Has least
responders to CRT

- Has lowest rate of
NYHA class III patients

- Has highest rate
of NYHA class III
patients

- Intermediate high
values for LVEF,
SPECT_pre_LVE
F
SPECT_pre_PSD,
SPECT_pre_PBW

- High proportion of patients
with Diabetes Mellitus
- Most significant response
rate from females
- Least rate of hypertensive
patients
- Has the highest mean and
a wider range of
SPECT_pre_LVEF
- Least mean of
SPECT_pre_EDV and
SPECT_pre_ESV values
- Least mean and standard
deviation of
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- Has the highest
mean and a wider
range of
SPECT_pre_ESV
values
- Has the highest
mean of
SPECT_pre_PSD and
SPECT_pre_50scar
values

- Has longest QRS
duration

- Has a high
SPECT_pre_50sc
ar mean and the
highest standard
deviation
- Has the highest
mean of
Echo_pre_EDV
values

SPECT_pre_50scar values

- Has the highest
mean and
standard deviation
of Echo_pre_ESV
values

5. DISCUSSION
Heart failure is a disease characterized by multiple syndromes and its response to therapies is
based on a couple of factors such as biomarkers, clinical data as well as imaging parameters.
Conventional techniques to predict outcomes within HF subgroups rely on isolated parameters
such as QRS morphology, presence or absence of specific comorbidities, HF cause, cardiac
structure and function amongst others. Thus, while the use of echocardiographic analysis tools to
assess cardiac structure and function can establish subgroups of HF patients at higher risk for
negative outcomes [12], echocardiographic data contains a lot of information representing
several time points in a cardiac cycle but this is replaced by single measurements in standard
quantitative data analysis which does not take into account the complex events of the entire
cardiac cycle.
In this study, hierarchical clustering as a form of unsupervised ML has been shown to aid the
integration of demographic data, clinical data, laboratory data and SPECT MPI parameters to
group patients with certain diseases such as HF. The research demonstrates the value of
combining different sets of descriptors to find patients that are more likely to respond to CRT as
compared to the results gotten from independent analysis of clinical parameters only. The results
from the study proves that unsupervised ML approaches can be used to combine standard clinical
parameters, ECG data and imaging parameters to provide a clinically interpretable and
meaningful classification of the heterogenous phenotypes of HF patients and the likelihood of
patients in certain subgroups to respond to specific treatment therapies.
While studies such as Chung et al [13] tried to find a single echocardiographic measure of
dyssynchrony to improve the selection of HF patients for CRT beyond the current guidelines
without success. This study combines heterogeneous data in an unsupervised manner to
ultimately find groups of patients with similar characteristics towards CRT response. The
unsupervised ML method used allows the natural clustering of patients and results in the
identification of patient subgroups in relation to their CRT response. Specifically, Phenogroups 2
and 3 had a higher rate of response at 68% and 63% respectively over the overall rate at 59%.
Phenogroups 1 and 4 had the least response rate at 50% and 46% respectively. About 14
parameters were statistically significant when compared within the 4 phenogroups.
SPECT_pre_PSD, Echo_pre_ESV, Echo_pre_EDV, LVEF, SPECT_pre_PBW, MI,
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SPECT_pre_LVEF, SPECT_pre_ESV, SPECT_pre_ESSI, SPECT_pre_ESE, SPECT_pre_EDV,
ECG_pre_QRSd, gender and ACEI_or_ARB.
Some limitation of this study includes the small size used as well as the fact that HC does not
work well with missing data. Though, the race parameter was significant in this study, this
cannot be ascertained as the data was majorly from North America, South America and Asia.
This means the data may be skewed towards a certain race over others and this is another
limitation of this study. Furthermore, the results gotten from this study need to be externally
validated. For future directions, further analysis using other unsupervised techniques such as
principal component analysis may be able to ascertain the result or to help uncover other relevant
clinical information. Another future work is the use of supervised classification to validate the
result gotten in this study.

6. CONCLUSION
This study concludes that unsupervised ML approaches such as HC can be used to integrate and
analyze ECG data, imaging parameters and clinical data to aid in the identification of HF patients
subgroups that are likely to respond to CRT. The results show that HC can provide a clinically
relevant classification of a heterogeneous cohort of HF patients which can serve as a data-driven
basis to identify patient phenogroups likely to respond to specific therapies. However, the
feasibility of this HC approach for patient phenogrouping in HF and its contribution to clinical
decision making needs to be evaluated with a large dataset, externally validated and used in a
prospective controlled trial.

7. REFERENCES
1) https://www.bostonscientific.com/en-US/patients/about-your-device/crt-devices/howcrts-work.html.
2) Albert K. Feeny, John Rickard, Kevin M. Trulock, Divyang Patel, Saleem Toro, Laurie
Ann Moennich, Niraj Varma, Mark J. Niebauer, Eiran Z. Gorodeski, Richard A. Grimm,
John Barnard, Anant Madabhushi, Mina K. Chung. Machine Learning of 12-Lead QRS
Waveforms to Identify Cardiac Resynchronization Therapy Patients With Differential
Outcomes. Arrhythmia and Electrophysiology. 2020;13
3) Camilla Normand, Cecilia Linde, Jagmeet Singh, Kenneth Dickstein. Indications for
Cardiac Resynchronization Therapy: A Comparison of the Major International
Guidelines, JACC: Heart Failure, Volume 6, Issue 4, 2018, Pages 308-316, ISSN 22131779.

4) Maja Cikes, Sergio Sanchez-Martinez, Brian Claggett, Nicolas Duchateau, Gemma
Piella, Constantine Butakoff, Anne Catherine Pouleur, Dorit Knappe, Tor BieringSørensen, Valentina Kutyifa, Arthur Moss, Kenneth Stein, Scott D. Solomon3 and Bart

13

Bijnens. Machine learning-based phenogrouping in heart failure to identify responders to
cardiac resynchronization therapy. European Journal of Heart Failure (2019) 21, 74–85
5) Saqib Ejaz Awan, Ferdous Sohel, Frank Mario Sanfilippo , Mohammed Bennamoun,
Girish Dwivedi. Machine learning in heart failure: ready for prime time. Curr Opin
Cardiol. 2018 Mar;33(2):190-195.
6) Sanchez-Martinez S, Duchateau N, Erdei T, Fraser AG, Bijnens BH, Piella G.
Characterization of myocardial motion patterns by unsupervised multiple kernel learning.
Med Image Anal 2017;35:70–8
7) Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, Bonow RO,
Huang CC, Deo RC. Phenomapping for novel classification of heart failure with
preserved ejection fraction. Circulation 2015;131:269–279.
8) J. L. Bruse et al., "Detecting Clinically Meaningful Shape Clusters in Medical Image
Data: Metrics Analysis for Hierarchical Clustering Applied to Healthy and Pathological
Aortic Arches," in IEEE Transactions on Biomedical Engineering, vol. 64, no. 10, pp.
2373-2383, Oct. 2017, doi: 10.1109/TBME.2017.2655364.
9) Matthew W. Segar, Kershaw V. Patel, Colby Ayers, Mujeeb Basit, W.H. Wilson Tang,
Duwayne Willett, Jarett Berry, Justin L. Grodin, and Ambarish Pandey. Phenomapping
of patients with heart failure with preserved ejection fraction using machine learningbased unsupervised cluster analysis. European Journal of Heart Failure (2020) 22, 148–
158. doi:10.1002/ejhf.1621
10) Jiangang Zou, Wei Hua, Yangang Su, Geng Xu, Liangrong Zhen. SPECT-Guided LV
Lead Placement for Incremental CRT Efficacy. Validated by a Prospective, Randomized,
Controlled Study.
11) Peix, A., Karthikeyan, G., Massardo, T. et al. Value of intraventricular dyssynchrony
assessment by gated-SPECT myocardial perfusion imaging in the management of heart
failure patients undergoing cardiac resynchronization therapy (VISION-CRT). J. Nucl.
Cardiol. (2019).
12) Cikes M, Solomon SD. Beyond ejection fraction: an integrative approach for assessment
of cardiac structure and function in heart failure. Eur Heart J 2016;37:1642 – 1650.
13) Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT,
Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J, Sutton MS, De Sutter J, Murillo J.
Results of the predictors of response to CRT (PROSPECT) trial. Circulation
2008;117:2608 – 2616.

14

APPENDIX: PYTHON SOURCE CODE

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

